Robert Babak Faryabi

2010-2015 National Cancer Institute, NIH, Bethesda, Bethesda, MD, United States 
"Robert Faryabi"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schwartz GW, Zhou Y, Petrovic J, et al. (2021) TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes. Cell Reports. 36: 109575
Cao Z, Budinich KA, Huang H, et al. (2021) ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency. Molecular Cell
Verma P, Zhou Y, Cao Z, et al. (2021) ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells. Nature Cell Biology
Kahn BM, Lucas A, Alur R, et al. (2020) The vascular landscape of human cancer. The Journal of Clinical Investigation
Rome KS, Stein SJ, Kurachi M, et al. (2020) Trib1 regulates T cell differentiation during chronic infection by restraining the effector program. The Journal of Experimental Medicine. 217
Schwartz GW, Zhou Y, Petrovic J, et al. (2020) TooManyCells identifies and visualizes relationships of single-cell clades. Nature Methods
Fasolino M, Goldman N, Wang W, et al. (2020) Genetic Variation in Type 1 Diabetes Reconfigures the 3D Chromatin Organization of T Cells and Alters Gene Expression. Immunity
Taylor DM, Aronow BJ, Tan K, et al. (2019) The Pediatric Cell Atlas: Defining the Growth Phase of Human Development at Single-Cell Resolution. Developmental Cell
Petrovic J, Zhou Y, Fasolino M, et al. (2019) Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques. Molecular Cell
Schwartz GW, Manning BS, Zhou Y, et al. (2018) Classes of ITD predict outcomes in AML patients treated with FLT3 inhibitors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
See more...